2015 Dietary Guidelines Management Team
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIDDK
|
2013
|
|
A qPCR-Based Approach to Develop Serological Assays for Influenza Virus: Comparison with Other Assays Using Clinical Samples
|
Research Initiative
|
FDA
|
NIAID
|
2012
|
|
Abuse Liability Evaluation for Research, Treatment, and Training (ALERTT)
|
Research Initiative
|
FDA
|
NIDA
|
2011
|
|
Adjuvant Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NIAID
|
2013
|
|
Adolescent Health Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, OS, SAMHSA
|
NICHD, NIDA, NIMH
|
2010
|
|
Advanced Anticonvulsant System Interagency Product Team
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
NIAID, NINDS
|
2011
|
|
Advancing Regulatory Science through Novel Research and Science-Based Technologies
|
Research Initiative
|
FDA
|
NCATS, NEI, NHLBI, NIBIB, NIDDK, NINDS, OD/ DPCPSI/ OSC, OD/ OSP
|
2010
|
|
Alcohol Clinical Trial Initiative (ACTIVE)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAAA, NIDA
|
2007
|
|
Alzheimer's Disease Neuroimaging Initiative
|
Research Initiative
|
FDA
|
NIA, NIBIB
|
2004
|
|
American Association of Blood Bank (AABB) International Biovigilance Network Task Force
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NHLBI
|
2006
|
|
Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCATS, NCI, NIDA, NINDS
|
2011
|
|
Anti-poliovirus Immune Assays and Testing Revertants from Clinical Trials of V-073, an Antiviral Agent
|
Research Initiative
|
FDA
|
NIAID
|
2011
|
|
Antiretroviral Pregnancy Registry
|
Resource Development
|
CDC, FDA
|
NICHD
|
1989
|
|
Asthma Outcomes Workshop
|
Meeting/ Workshop
|
AHRQ, CDC, CMS, FDA, HRSA
|
NHLBI, NIA, NIAID, NICHD, NIEHS, NIMHD, NINR
|
2009
|
|
Autoimmune Diseases Coordinating Committee (ADCC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
CSR, FIC, NCATS, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR
|
1998
|
|
B-24 Dietary Guidelines
|
Meeting/ Workshop
|
CDC, FDA, OS
|
NICHD
|
2013
|
|
Best Pharmaceuticals for Children Act
|
Research Initiative
|
FDA, HRSA
|
NHLBI, NICHD, NIMH
|
2002
|
|
Best Pharmaceuticals for Children Act Activities
|
Committee, Advisory Group, or Work Group
|
FDA
|
NHLBI, NICHD, NIMH
|
Unknown
|
|
Big Data to Knowledge
|
Meeting/ Workshop
|
AHRQ, CMS, FDA, OS
|
OD/ DPCPSI, OD/ DPCPSI/ OSC
|
2013
|
|
Biomarkers of Nutrition for Development (BOND) Meetings
|
Meeting/ Workshop
|
CDC, FDA, HRSA, OS
|
FIC, NCI, NHLBI, NICHD, NIDDK, OD/ DPCPSI/ ODP
|
2012
|
|
BioMedical Informatics Coordinating Committee Common Data Elements (CDE) Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIDA
|
2007
|
|
Breastfeeding and Human Lactation Research Scientific Interest Group (BALSIG) Special Interest Group
|
Committee, Advisory Group, or Work Group
|
FDA, OSG
|
NCI, NICHD, NIDDK, OD/ DPCPSI/ ORWH
|
2013
|
|
Cancer and Women's Health Interagency Agreement
|
Research Initiative
|
FDA
|
NCI
|
2013
|
|
CDC/HRSA Advisory Committee on HIV, Viral Hepatitis, and STD Prevention and Treatment (CHACHSPT)
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
OD/ DPCPSI/ OAR
|
2002
|
|
Cell Therapy for Lung Diseases
|
Meeting/ Workshop
|
FDA
|
NHLBI
|
2012
|
|
Chemical Integrated Program Team (IPT)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NICHD
|
2008
|
|
Chronic Fatigue Syndrome Advisory Committee (CFSAC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, OS
|
CSR, NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIDCR, NIDDK, NIEHS, NIMH, NINDS, NINR, NLM, OD/ DPCPSI/ ORWH
|
2003
|
|
Clinical and Translational Research Course for PhD Students
|
Training Initiative
|
FDA
|
CC, NCATS, NCI, NHLBI, NIAID, NIDA, NIDDK, NIGMS, NIMH
|
2012
|
|
Clinical Investigator Interagency Working Group for the Development of Antiviral Influenza Therapeutics
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2009
|
|
Clinical Islet Transplantation Consortium
|
Research Initiative
|
CMS, FDA
|
NIAID, NIDDK
|
2004
|
|
Clinical Trials Working Group (CTWG) Steering Committee System
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI
|
2008
|
|
ClinicalTrials.gov
|
Resource Development
|
FDA
|
CC, NCATS, NCCAM, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ OSP
|
2000
|
|
Collaborative Islet Transplant Registry Ad Hoc Scientific Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA, HRSA
|
NIAID
|
2009
|
|
Collection and Characterization of HIV Variant Strains in Cameroon for an HIV Panels Project
|
Research Initiative
|
FDA
|
NIAID
|
2009
|
|
Comparative Effectiveness Research Coordinating Committee
|
Committee, Advisory Group, or Work Group
|
AHRQ, CMS, FDA
|
CC, CSR, NCATS, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODP, OD/ OSP
|
2008
|
|
Computational Toxicology for NIH Medications Discovery
|
Research Initiative
|
FDA
|
NIDA
|
2000
|
|
Computer-aided Diagnosis for Radiology Images
|
Research Initiative
|
FDA
|
CC
|
2004
|
|
Conducting Comprehensive Toxicological Assessments
|
Research Initiative
|
FDA
|
NIEHS
|
1996
|
|
Consortium for TB Biomarkers (CTB2)
|
Research Initiative
|
FDA
|
NIAID
|
2012
|
|
Countermeasures Against Chemical Threats (CounterACT) Research Network Annual Symposium
|
Meeting/ Workshop
|
CDC, FDA, OS
|
NEI, NIAID, NIAMS, NICHD, NIEHS, NIGMS, NINDS
|
2006
|
|
Creutzfeldt-Jakob Disease Surveillance in Recipients of Human Growth Hormone, National Hormone and Pituitary Program (NHPP)
|
Resource Development
|
CDC, FDA
|
NIDDK
|
1985
|
|
DailyMed
|
Resource Development
|
FDA
|
NLM
|
2005
|
|
Demand Reduction Interagency Working Groups
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, OS, SAMHSA
|
NIAAA, NIDA
|
2009
|
|
Development and Use of a Non-human Primate Model of Pertussis Diseases and Transmission
|
Research Initiative
|
FDA
|
NIAID
|
2011
|
|
Development of a High Throughput Quantitative PCR Assay to Detect Neutralizing Antibody to Human Respiratory Syncytial Viruses
|
Research Initiative
|
FDA
|
NIAID
|
2010
|
|
Development of Filovirus BSL-D Neutralization and Enzyme-Linked Immunosorbent Assay (ELISA) Tests for Licensing of Vaccines and Immunoglobulin Preparations
|
Research Initiative
|
FDA
|
NIAID
|
2013
|
|
Development of Live Biotherapeutics Workshop
|
Meeting/ Workshop
|
FDA
|
NCI, NIAID
|
2013
|
|
Development of the HHS Framework for Guiding Funding Decisions about Research Proposals with the Potential for Generating Highly Pathogenic Avian Influenza H5N1 Viruses that are Transmissible among Mammals by Respiratory Droplets
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
2012
|
|
DHHS Women's Health and the Environment Interagency Committee
|
Committee, Advisory Group, or Work Group
|
ATSDR, CDC, FDA, HRSA, IHS, OS
|
NCI, NICHD, NIEHS
|
2000
|
|
Diabetes Mellitus Interagency Coordinating Committee (DMICC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS
|
CSR, NCATS, NCCAM, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM
|
1974
|
|
Diet-Induced Hypomethylation in Preneoplastic Liver
|
Research Initiative
|
FDA
|
NCI
|
2004
|
|
Dietary Supplements Ingredient Database (DSID)
|
Resource Development
|
CDC, FDA
|
NCI, NHLBI, NIDDK, OD/ DPCPSI/ ODP
|
2002
|
|
Digital Quantitation of Plasma Cells in Marrow Biopsies
|
Research Initiative
|
FDA
|
CC
|
2011
|
|
Disaster Research Response Project
|
Research Initiative
|
ATSDR, CDC, FDA, OS
|
NIEHS, NLM
|
2013
|
|
Domestic Scheduling to Control New Drugs of Abuse, with NIDA-Funded Testing Conducted in Support of DEA Scheduling Recommendations to the FDA
|
Research Initiative
|
FDA, OS
|
NIDA
|
Unknown
|
|
Dominantly Inherited Alzheimer's Network (DIAN): International Network for the Identification, Evaluation, and Follow up of Families with Early Onset of Dominantly Inherited Alzheimer's Disease
|
Research Initiative
|
FDA
|
NIA
|
2008
|
|
Drug Induced Liver Injury Network (DILIN)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIDDK
|
2003
|
|
Electronic Research Administration (eRA)
|
Other
|
AHRQ, CDC, FDA, SAMHSA
|
CSR, FIC, NCATS, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ OER
|
2005
|
|
Endocrinologic and Metabolic Drugs Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2003
|
|
European-US Pediatric Formulations Excipients Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD
|
2010
|
|
Evaluation of Patient Reported Outcomes Following LASIK Surgery.
|
Research Initiative
|
FDA
|
NEI
|
2009
|
|
Extracellular RNA Communication
|
Research Initiative
|
FDA
|
NCATS, OD/ DPCPSI, OD/ DPCPSI/ OSC
|
2013
|
|
FDA Arthritis Drugs Advisory Committee Meeting
|
Meeting/ Workshop
|
CDC, FDA
|
NIMH
|
2012
|
|
FDA Blood Products Advisory Committee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
CC, NHLBI
|
2007
|
|
FDA Cancer Diagnosis Program (CDP) Monthly Meeting
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI
|
2010
|
|
FDA Cancer Imaging Program (CIP) Bi-annual Meeting
|
Meeting/ Workshop
|
FDA
|
NCI
|
2011
|
|
FDA Center of Drug Evaluation and Research (CDER) Workgroup
|
Committee, Advisory Group, or Work Group
|
FDA
|
CC
|
2011
|
|
FDA Drug Safety Oversight Board
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS
|
NCI, OD/ OSP
|
2005
|
|
FDA Medical Countermeasures initiative (MCMi) Regulatory Science Steering Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2012
|
|
FDA Memorandum of Understanding with NHLBI [Docket No. FDA–2008–N–0043]
|
Committee, Advisory Group, or Work Group
|
FDA
|
NHLBI
|
2008
|
|
FDA Pediatric Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD
|
2009
|
|
FDA-NCI Monthly Meeting
|
Meeting/ Workshop
|
FDA
|
NCI
|
1991
|
|
Fecal Microbiota for Transplantation
|
Meeting/ Workshop
|
FDA
|
NIAID
|
2013
|
|
Federal Breastfeeding Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
2009
|
|
Federal Dietary Reference Intakes Steering Committee
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, OS
|
NIDDK
|
2005
|
|
Federal HIV/AIDS Web Council (AIDS.gov)
|
Resource Development
|
CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NCI, NIAID, NIDA, NLM, OD/ DPCPSI/ OAR
|
2006
|
|
Federal Interagency Working Group on Vitamin D
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA
|
NEI, NICHD
|
Unknown
|
|
Federal mHealth Collaborative
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, SAMHSA
|
NCI, NHLBI, NIBIB, NIDA, NLM, OD/ DPCPSI/ OBSSR
|
2011
|
|
Federal Supply and Demand of Isotopes
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NIBIB
|
2012
|
|
Federal Working Group on Bone Diseases
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, OS
|
CSR, NCATS, NCCAM, NCI, NEI, NIA, NIAAA, NIAMS, NICHD, NIDCR, NIDDK, NIEHS, NIMH, OD/ DPCPSI/ ORWH
|
1993
|
|
Federal Working Group on Dietary Supplements
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA
|
CSR, FIC, NCATS, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAMS, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODP
|
2005
|
|
FedTel: Cross-Federal work group on telehealth
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS
|
NIBIB, NLM, OD/ DPCPSI/ OBSSR
|
2011
|
|
Filovirus Animal Non-Clinical Group (FANG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2011
|
|
Food Safety and Nutrition Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIDDK, NIEHS
|
2012
|
|
Gain-of-Function Research on Highly Pathogenic Avian Influenza H5N1 Viruses: An International Consultative Workshop
|
Meeting/ Workshop
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
2012
|
|
Genetic, functional, and epidemiologic studies of chronic hepatitis C
|
Research Initiative
|
FDA
|
NCI
|
2010
|
|
Genome in a Bottle Consortium
|
Resource Development
|
CDC, FDA
|
NCI, NHGRI, NLM
|
2012
|
|
Guidelines for Prevention of Mother to Child HIV Transmission; Guidelines for Pediatric Antiretroviral Treatment; Guidelines for Adult Antiretroviral Treatment; Guidelines for Prevention and Treatment of Opportunistic Infections in Adults
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
NIAID, NICHD
|
1998
|
|
Health Literacy Work Group
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG
|
NCI, NEI, NHGRI, NHLBI, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIEHS, NIMH, NINR, NLM, OD/ DPCPSI/ OBSSR, OD/ OCPL
|
2006
|
|
Healthcare Systems (HCS) Research Collaboratory
|
Research Initiative
|
AHRQ, CDC, FDA
|
NCATS, NCCAM, NCI, NHGRI, NHLBI, NIA, NIAMS, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR, OD/ DPCPSI/ OSC
|
2011
|
|
Healthy People 2010 - Kidney Disease
|
Public Education Campaign
|
CDC, CMS, FDA, HRSA, OS
|
NIDDK
|
1998
|
|
Healthy People 2020 - Blood Diseases, Disorders, and Safety
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, OS
|
NHLBI
|
2006
|
|
Healthy People 2020 - Environmental Health Topic Area
|
Committee, Advisory Group, or Work Group
|
AHRQ, ATSDR, CDC, FDA, OS
|
NIEHS
|
2008
|
|
Hematopoietic Stem Cell Transplantation Interagency Working Group
|
Committee, Advisory Group, or Work Group
|
FDA, HRSA
|
CC, NCI, NHLBI, NIAID, NIDDK
|
1998
|
|
Hemoglobinopathy Uniform Medical Language Ontology Project
|
Resource Development
|
AHRQ, CDC, FDA, HRSA, OS
|
NHLBI, NIAMS, NICHD, NLM
|
2008
|
|
HHS Action Plan for the Prevention, Care and Treatment of Viral Hepatitis Interagency Implementation Group (VHIG)
|
Research Initiative
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, SAMHSA
|
NIAID, NIDA, NIDDK
|
2011
|
|
HHS Advisory Committee on Blood & Tissue Safety & Availability (ACBTSA)
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, HRSA, OS
|
NHLBI
|
1997
|
|
HHS Advisory Council for the Elimination of Tuberculosis
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA, IHS, OS, SAMHSA
|
NIAID
|
2009
|
|
HHS Behavioral Health Coordinating Committee (BHCC)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NIAAA, NIDA, NIMH, OD/ DPCPSI/ OBSSR, OD/ OCPL
|
2009
|
|
HHS Behavioral Health Coordinating Committee (BHCC) Subcommittee on Prescription Drug Abuse
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NIDA
|
2009
|
|
HHS Biannual Dual Use Research of Concern (DURC) Inventory
|
Resource Development
|
CDC, FDA, OS
|
CC, FIC, NCATS, NCCAM, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI, OD/ OSP
|
2012
|
|
HHS Biomedical Advanced Research and Development Authority (BARDA) Radiological/Nuclear Integrated Program Team
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
2007
|
|
HHS Blood, Organ, and Tissue Senior Executive Council (BOTSEC)
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, OS
|
CC, NHLBI
|
1997
|
|
HHS Diagnostics Integrated Program Team (DxIPT)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2012
|
|
HHS Dietary Guidance Review Committee
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, FDA, HRSA, IHS, OS
|
NIDDK
|
1990
|
|
HHS H5N1 Gain-of-Function Review Group (HHG Review Group)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
2013
|
|
HHS Influenza Diagnostics Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2012
|
|
HHS Initiative on Multiple Chronic Conditions
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, OS
|
NIA, OD/ DPCPSI/ OBSSR, OD/ OSP
|
2009
|
|
HHS Lyme and Tick Borne Diseases Work Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
2011
|
|
HHS National HIV/AIDS Strategy Implementation Group
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG
|
OD/ DPCPSI/ OAR
|
2009
|
|
HHS Nutrition Policy Board
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, FDA, HRSA, IHS, OS, SAMHSA
|
NIDDK
|
1986
|
|
HHS Tissue and Organ Donor Epidemiology Study (TODES) Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
NHLBI
|
2012
|
|
HHS Viral Hepatitis Interagency Working Group
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
CC, NCCAM, NCI, NHLBI, NIAAA, NIAID, NICHD, NIDA, NIDDK, NIMHD, OD/ DPCPSI/ OAR
|
2009
|
|
HHS Working Group on the Epilepsies
|
Committee, Advisory Group, or Work Group
|
ACL, CDC, CMS, FDA, HRSA, OS
|
NIA, NICHD, NIMH, NINDS
|
2012
|
|
Human Nutrition Research Information Management (HNRIM) System
|
Resource Development
|
CDC, FDA, HRSA
|
NIDDK
|
1985
|
|
ICARE: Interagency Collaborative to Advance Research in Epilepsy
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA, OS
|
FIC, NCATS, NHGRI, NHLBI, NIA, NIAAA, NIAMS, NIBIB, NICHD, NIDA, NIGMS, NIMH, NINDS, NINR
|
2003
|
|
Image-guided Interventional Therapeutics
|
Research Initiative
|
FDA
|
CC, NCI
|
2004
|
|
Improving Technical Standards and Molecular Tools for Probiotics Research and Development
|
Research Initiative
|
FDA
|
NCCAM
|
2008
|
|
Influenza (Flu) Risk Management Meeting (FRMM)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
Unknown
|
|
Influenza Vaccine Manufacturing Improvement Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
Unknown
|
|
Inter-Agency Committee on Drug Control (ICDC)
|
Committee, Advisory Group, or Work Group
|
FDA, OS, SAMHSA
|
NIDA
|
1981
|
|
Inter-Agency Working Group on Technology Transfer
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
OD/ OER, OD/ OIR/ OTT
|
1990
|
|
Interactive Training Tool to Teach Health Care Providers About Reducing Prescription Opioid Abuse
|
Research Initiative
|
AHRQ, CDC, FDA, OS, SAMHSA
|
NIDA, NINDS
|
2013
|
|
Interagency Agreement for Communications on Prevention of Underage Tobacco Use
|
Public Education Campaign
|
FDA
|
NCI
|
2012
|
|
Interagency Artificial Pancreas Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIBIB, NICHD, NIDDK
|
2007
|
|
Interagency Autism Coordinating Committee (IACC)
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, CDC, CMS, FDA, HRSA
|
NICHD, NIDCD, NIEHS, NIMH, NINDS
|
2000
|
|
Interagency Chemical Hazards Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NINDS
|
2007
|
|
Interagency Committee on Emergency Medical Services for Children Research (ICER)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA, OS, SAMHSA
|
NIAID, NIAMS, NICHD, NIDCR, NIGMS, NIMH, NINR
|
1998
|
|
Interagency Committee on Human Growth Hormone
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD, NIDDK, NINDS
|
1984
|
|
Interagency Coordinating Committee on Human Growth Hormone and Creutzfeldt-Jakob Disease
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD, NIDDK, NINDS
|
1985
|
|
Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM)
|
Research Initiative
|
ATSDR, CDC, FDA
|
NCI, NEI, NIAID, NIEHS, NLM
|
2000
|
|
Interagency Group on Alzheimer's Disease and Related Dementias for implementation of the National Alzheimer's Project Act
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA
|
NIA
|
2011
|
|
Interagency Midazolam Product Coordination Team
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
NIAID, NINDS
|
2011
|
|
Interagency Modeling and Analysis Group (IMAG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
CSR, FIC, NCATS, NCI, NHGRI, NHLBI, NIA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NLM, OD/ DPCPSI/ OBSSR
|
2003
|
|
Interagency Pain Research Coordinating Committee (IPRCC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, IHS, OS, SAMHSA
|
NCCAM, NIDA, NIDCR, NINDS, NINR
|
2011
|
|
Interagency Select Agent Review Group (ISARG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
Unknown
|
|
Interagency Subcommittee on Disability Statistics (ISDS)
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NIDCD
|
1996
|
|
Interagency Task Force on Antimicrobial Resistance (ITFAR)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, OS
|
NIAID
|
1999
|
|
Interagency Working Group on Neuroscience
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIA, NIDA, NIMH, NINDS, NINR, OD/ DPCPSI/ OBSSR
|
2012
|
|
INTERMACS - Interagency Registry for Mechanically Assisted Circulatory Support
|
Resource Development
|
CMS, FDA
|
NHLBI
|
2005
|
|
Intradepartmental Council for Native American Affairs (ICNAA)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NIMHD
|
2004
|
|
Intragovernmental Select Agents and Toxins Technical Advisory Committee (ISATTAC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
2005
|
|
Joint Committee and Joint Commission Meetings
|
Meeting/ Workshop
|
CDC, FDA, OS
|
FIC, NCI, NIAID
|
2011
|
|
Joint Fellowship Program
|
Training Initiative
|
FDA
|
NCI
|
2005
|
|
Kidney Interagency Coordinating Committee (KICC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS
|
NHLBI, NIA, NIDDK
|
Unknown
|
|
Let's Move/HHS Healthy Weight Task Force
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NHLBI, NIDDK
|
2012
|
|
Lupus Federal Working Group
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA, OS
|
NCCAM, NEI, NHLBI, NIAID, NIAMS, NICHD, NIDCR, NIDDK, NIMHD, NINDS
|
2003
|
|
Malaria Transmission
|
Research Initiative
|
FDA
|
NIAID
|
2013
|
|
Medical Planning and Response to a Nuclear Detonation Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NCI
|
2012
|
|
Memorandum of Understanding (MOU) between the FDA/Center for Biologics Evaluation and Research (FDA/CBER) and NIH/NINDS
|
Other
|
FDA
|
NINDS
|
2002
|
|
Microphysiological Systems for Drug Efficacy and Toxicity Testing
|
Research Initiative
|
FDA
|
NCATS, NCI, NEI, NHLBI, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIGMS, NINDS, NINR, OD/ DPCPSI, OD/ DPCPSI/ ORWH
|
2012
|
|
Microsystems Team
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIDDK, NINDS
|
2011
|
|
Mobile Applications for Data Collection on Adverse Events of Medication or Device During Public Health Emergencies
|
Resource Development
|
FDA
|
NLM
|
2012
|
|
mPOWER mHealth Group
|
Research Initiative
|
CDC, CMS, FDA, HRSA, IHS
|
CIT, FIC, NCCAM, NCI, NEI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR, NLM, OD/ DPCPSI/ OBSSR
|
2011
|
|
Multi-Agency Tissue Engineering Science (MATES) Interagency Working Group
|
Committee, Advisory Group, or Work Group
|
CMS, FDA
|
NHLBI, NIAMS, NIBIB, NICHD, NIDCD, NIDCR
|
2000
|
|
Muscular Dystrophy Coordinating Committee (MDCC)
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, FDA, HRSA
|
NHLBI, NIAMS, NICHD, NINDS
|
2002
|
|
Naloxone Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIDA
|
2011
|
|
Nanomaterial Registry
|
Resource Development
|
FDA
|
NCI, NIBIB, NIEHS
|
2007
|
|
Nanotechnology Characterization Laboratory
|
Research Initiative
|
FDA
|
NCI, NIEHS
|
2004
|
|
National Asthma Control Initiative (NACI)/National Asthma Education and Prevention Program (NAEPP)
|
Public Education Campaign
|
CDC, FDA
|
NHLBI, NIAID, NIEHS
|
2008
|
|
National Asthma Education and Prevention Program Federal Liaison Group on Asthma (FLGA)
|
Committee, Advisory Group, or Work Group
|
AHRQ, ATSDR, CDC, CMS, FDA, HRSA, OS
|
NHLBI, NIA, NIAID, NICHD, NIEHS, NIMHD, NINR
|
1998
|
|
National Blood Disorders Program
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, OS
|
NHLBI, NIMHD
|
2011
|
|
National Food and Nutrient Analysis Program (NFNAP)
|
Research Initiative
|
CDC, FDA, IHS
|
NCI, NEI, NHLBI, NIA, NICHD, NIDCR, NIDDK, OD/ DPCPSI/ ODP, OD/ DPCPSI/ ORWH
|
1997
|
|
National Health and Nutrition Examination Survey (NHANES)
|
Health Survey
|
CDC, FDA, OS
|
NCI, NHLBI, NIA, NIDDK, OD/ DPCPSI, OD/ DPCPSI/ ODP
|
1999
|
|
National Interagency Confederation for Biological Research
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NCI, NIAID
|
2002
|
|
National Kidney Disease Education Program
|
Public Education Campaign
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS
|
NHLBI, NIDDK
|
1998
|
|
National Partnership for Action to End Health Disparities (NPA): Federal Interagency Health Equity Team (FIHET)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIMH, NIMHD, NINR, OD/ DPCPSI/ ODP
|
2006
|
|
National Program to Reduce Cardiovascular Risk (NPRCR) Coordinating Committee
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS
|
NHLBI
|
2011
|
|
National Program to Reduce Cardiovascular Risk (NPRCR) Federal Subcommittee
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS
|
NCI, NHLBI, NIDDK, NIMHD, NINDS, OD/ DPCPSI/ ODP
|
2012
|
|
National Robotics Initiative
|
Research Initiative
|
FDA
|
NEI, NIA, NIBIB, NICHD, NIDCD, NINDS, NINR
|
2009
|
|
National Science Advisory Board for Biosecurity (NSABB)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
2004
|
|
National Toxicology Program (NTP) Executive Committee
|
Committee, Advisory Group, or Work Group
|
ATSDR, CDC, FDA
|
NCI, NIEHS
|
1985
|
|
NCI Clinical Trials and Translational Research Advisory Committee (CTAC)
|
Committee, Advisory Group, or Work Group
|
CMS, FDA
|
NCI
|
2007
|
|
NCI National Cancer Informatics Program (NCIP) Nanotechnology Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NCI, NHLBI, NIBIB, NIEHS
|
2008
|
|
NCI/FDA Federal Investigator Registry of Biomedical Information Research Data (FIREBIRD)
|
Resource Development
|
FDA
|
NCI
|
2004
|
|
NCI/FDA Memorandum of Understanding for Drug related information
|
Resource Development
|
FDA
|
NCI
|
2012
|
|
NCI/FDA Memorandum of Understanding for Proteomics
|
Research Initiative
|
FDA
|
NCI
|
2006
|
|
Neural Interfaces Conference
|
Meeting/ Workshop
|
FDA
|
CSR, NEI, NIA, NIBIB, NICHD, NIDCD, NINDS
|
2006
|
|
Newborn Drug Development Planning Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NHLBI, NICHD, NLM
|
2011
|
|
NHLBI Federal COPD Workshop
|
Committee, Advisory Group, or Work Group
|
ACL, CDC, CMS, FDA, HRSA, IHS
|
NCCAM, NHLBI
|
2013
|
|
NIAID International tuberculosis (TB) Working Group
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, IHS, OS
|
FIC, NHLBI, NIAID, NICHD, NIDA
|
2003
|
|
NIH Guide for Grants and Contracts
|
Resource Development
|
AHRQ, CDC, FDA
|
CIT, CSR, OD/ OER
|
2007
|
|
NIH Recombinant DNA Advisory Committee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NCI, NHGRI, NIAID, NINDS, OD/ OSP
|
1974
|
|
NIH Translational Research Interest Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
CC, CIT, CSR, NCATS, NCCAM, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI, OD/ OER, OD/ OIR, OD/ OSP
|
2008
|
|
NIH-FDA Interagency Clinical Outcome Assessments Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
CC, NCCAM, NCI, NHLBI, NIA, NIAMS, NICHD, NIDA, NIDDK, NIMH, NINDS, OD/ DPCPSI
|
2010
|
|
NIH-FDA Leadership Council
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NHLBI, NIAID, NIDDK, NIGMS, NIMH, NINDS, OD/ OSP
|
2010
|
|
NIH-FDA Tobacco Regulatory Science Workgroup
|
Committee, Advisory Group, or Work Group
|
FDA
|
CSR, FIC, NCI, NEI, NHGRI, NHLBI, NIAAA, NICHD, NIDA, NIDCD, NIDCR, NIEHS, NIGMS, NIMH, NINDS, NINR, NLM, OD/ DPCPSI/ OBSSR
|
2011
|
|
NNI Nanotechnology Signature Initiative on Nanotechnology for Sensors and Sensors for Nanotechnology: Improving and Protecting Health, Safety, and the Environment
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NCI, NIBIB
|
2012
|
|
NNI Nanotechnology Signature Initiative on Nanotechnology Knowledge Infrastructure: Enabling National Leadership in Sustainable Design
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NCI, NIBIB
|
2012
|
|
Non-Allergic Rhinitis Workshop
|
Meeting/ Workshop
|
FDA
|
NIAID
|
2012
|
|
North American Plan For Animal and Pandemic Influenza
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
2007
|
|
Nutrition Coordinating Committee (NCC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA, IHS, OS
|
CC, CIT, CSR, FIC, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, OD/ DPCPSI, OD/ DPCPSI/ OBSSR
|
1975
|
|
Office of Science and Technology Mo99 Stakeholders Working Group
|
Committee, Advisory Group, or Work Group
|
CMS, FDA, OSG
|
NCI, NIBIB
|
2011
|
|
Pathways to Prevention Workshop
|
Health Survey
|
AHRQ, CDC, FDA, IHS, OS, SAMHSA
|
NCI, NIA, NIDA, NINDS, OD/ DPCPSI/ ODP
|
2012
|
|
Patient-Reported Outcomes Measurement Information System (PROMIS)
|
Research Initiative
|
CDC, CMS, FDA, SAMHSA
|
NCCAM, NCI, NHLBI, NIAID, NIAMS, NICHD, NIDA, NIDDK, NIGMS, NIMH, NINDS, OD/ DPCPSI, OD/ DPCPSI/ OSC
|
2004
|
|
Pertussis Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2012
|
|
PHS MSM Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NHLBI
|
2008
|
|
PHS Review Committee: Use of Marijuana in Clinical Research
|
Committee, Advisory Group, or Work Group
|
FDA, OS, SAMHSA
|
NCCAM, NIDA, NIMH, NINDS
|
2011
|
|
Planning Committee for the NIH Consensus Workshop on Effectiveness and Risks of Long-Term Opioid Treatment of Chronic Pain
|
Meeting/ Workshop
|
FDA, HRSA
|
NCI, NHLBI, NIA, NICHD, NIDCR, NIDDK, NINDS, NINR, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODP, OD/ DPCPSI/ ORWH
|
2013
|
|
Pluripotent Stem Cells in Translation: Early Decisions
|
Meeting/ Workshop
|
FDA
|
NHLBI, NIDCR, NINDS, OD/ DPCPSI
|
2011
|
|
Population Assessment of Tobacco and Health Study
|
Health Survey
|
FDA
|
NIDA
|
2011
|
|
Potential of Candidate Cell Substrates for Vaccine Production to Propagate the Agents of Transmissible Spongiform Encephalopathies
|
Research Initiative
|
FDA
|
NIAID
|
2004
|
|
Public Health Emergency Medical Countermeasures Enterprise (PHEMCE)
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, FDA, OS, SAMHSA
|
NIAID, NIAMS, NICHD, NINDS, NLM
|
2007
|
|
Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Chemical Integrated Product Development Team (IPT)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, NINDS
|
2007
|
|
Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Chemical Requirements Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, NICHD, NIEHS, NINDS
|
2007
|
|
Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Enterprise Executive Committee (EEC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
2010
|
|
Quantitative data mining for drug-adverse event safety signal detection using MEDLINE
|
Research Initiative
|
FDA
|
NLM
|
2012
|
|
RABRAT (Radiobiology Bioterrorism Research and Training Group)
|
Meeting/ Workshop
|
FDA, OS
|
NCI
|
2003
|
|
Rapid State Evaluation Reviewer
|
Research Initiative
|
FDA
|
NICHD
|
2013
|
|
Reciprocal Educational and Training Partnerships between FDA/CDER and the NIH Clinical Center
|
Training Initiative
|
FDA
|
CC, NCI, NIAID, NIMH, NINDS
|
2007
|
|
Sabbatical in Clinical Research Management Program
|
Training Initiative
|
FDA, OS
|
CC, FIC, NCATS, NEI, NHLBI, NIAID, NLM
|
2009
|
|
Safety Reporting Portal
|
Resource Development
|
FDA
|
OD/ OSP
|
2008
|
|
Sequencing Quality Control (SEQC) Toxicogenomics (TGMX) Study
|
Research Initiative
|
FDA
|
NIEHS
|
2012
|
|
Specialized Centers of Research (SCOR) on Sex and Gender Factors Affecting Women's Health
|
Research Initiative
|
FDA
|
NIAMS, NICHD, NIDA, NIDDK, NIMH, OD/ DPCPSI/ ORWH
|
2002
|
|
Standardization of Methods to Generate Spiked Clinical Samples for Use in Studies to Support FDA Clearance of Diagnostics for Low Prevalence Pathogens
|
Research Initiative
|
FDA
|
NIAID
|
2013
|
|
Studies in the Treatment of Anthrax Edema Toxin Associated Shock: The Role of Conventional Hemodynamic Support Alone or Together with a PA Directed mAb
|
Research Initiative
|
FDA
|
CC
|
2012
|
|
Subcommittee on Nanoscale Science, Engineering, and Technology
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NCI, NIBIB, NIEHS, OD/ OSP
|
2001
|
|
Subpopulations and Intermediate Outcome Measures in Chronic Obstructive Pulmonary Disease (COPD)
|
Research Initiative
|
FDA
|
NHLBI
|
2006
|
|
Targeting of Interleukin-13 Receptor a2 for Treatment of Head and Neck Squamous Cell Carcinoma Induced by Conditional Deletion of TGF-ß and PTEN Signaling
|
Research Initiative
|
FDA
|
NIDCD, NIDCR
|
2010
|
|
Task Force on Environmental Health Risks and Safety Risks to Children: Coordinated Federal Action Plan to Reduce Racial and Ethnic Asthma Disparities
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG
|
NCMHD, NHLBI, NIAID, NICHD, NIEHS, NINR
|
2009
|
|
Text 4 Baby Program Evaluation Technical Advisory Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, OS, SAMHSA
|
NICHD
|
2010
|
|
The Federal Tuberculosis Task Force
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
FIC, NCATS, NHLBI, NIAAA, NIAID, NICHD, NIDA
|
1991
|
|
The Foundation for the NIH Biomarkers Consortium
|
Research Initiative
|
CMS, FDA
|
NCI, NHLBI, NIA, NIAID, NIAMS, NIBIB, NICHD, NIDDK, NIMH, NINDS
|
2006
|
|
The Impact of Tobacco Use on Oral Health and the Oral Microbiome
|
Research Initiative
|
CDC, FDA
|
NCI
|
2012
|
|
The Interagency Committee on Human Nutrition Research (ICHNR)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIDDK
|
2013
|
|
The Intersection of Violence and HIV Risk in Women Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, FDA, HRSA, IHS, OS
|
OD/ DPCPSI/ OAR
|
2012
|
|
The NIH Bone Marrow Stromal Cell Transplantation Center
|
Research Initiative
|
FDA
|
CC, NCI, NHLBI, NIAID, NIAMS, NIBIB, NIDCR, NINDS
|
2009
|
|
The Pharmacology Research Associate (PRAT) Program
|
Training Initiative
|
FDA
|
NIGMS
|
1965
|
|
The Science of Sex and Gender in Human Health
|
Training Initiative
|
FDA
|
OD/ DPCPSI/ ORWH
|
2006
|
|
The Trans-NIH Rare Diseases Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
CC, CSR, FIC, NCATS, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NLM
|
2004
|
|
Therapeutics for Rare and Neglected Diseases (TRND)/FDA Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
CC, NCATS, NHGRI, NHLBI, NICHD, NINDS
|
2009
|
|
Tobacco and Nicotine Research Interest Group (TANRIG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, SAMHSA
|
NCI, NHGRI, NHLBI, NIAAA, NIAID, NICHD, NIDA, NIEHS, NIMH, NINR, OD/ DPCPSI/ OBSSR
|
2003
|
|
Tobacco Regulatory Science Program (TRSP)
|
Research Initiative
|
FDA
|
NCI, OD/ DPCPSI/ ODP, OD/ OER
|
2012
|
|
Toxicology in the 21st Century (Tox21) Program
|
Research Initiative
|
FDA
|
NCATS, NIEHS
|
2008
|
|
Trans-Atlantic Task Force on Antimicrobial Resistance (TATFAR)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
2009
|
|
Trans-NIH Plan for HIV-Related Research
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, OS
|
CC, CSR, FIC, NCATS, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI/ OAR, OD/ DPCPSI/ ORIP, OD/ DPCPSI/ ORWH
|
1994
|
|
Treating for Two: Safe Medication Use in Pregnancy Initiative
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA
|
NICHD, OD/ DPCPSI/ ORWH
|
2012
|
|
U. S. Government Interagency Working Group on Nanotechnology Environmental, and Health Implications (NEHI), of the Nanoscale Science, Engineering, and Technology Subcommittee (NSET) of the National Science and Technology Council (NSTC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NCI, NIBIB, NIEHS
|
2005
|
|
U.S. Government Interagency Working Group on Nanotechnology Environmental, and Health Implications (NEHI), of the Nanoscale Science, Engineering, and Technology Subcommittee (NSET) of the National Science and Technology Council (NSTC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NCI, NHGRI, NIBIB, NIEHS
|
2005
|
|
United State Government (USG) Interagency Forensics Advisory Board
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2012
|
|
Urology Interagency Coordinating Committee
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA
|
NCCAM, NCI, NIA, NICHD, NIDDK, NINDS
|
Unknown
|
|
Wireless Medical Technologies
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
CIT, NIA, NIAAA, NIAID, NIBIB, NICHD, NIMH, NINDS, NLM
|
2010
|
|
Working Groups to Develop Federal HIV/AIDS Prevention and Treatment Guidelines
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
NICHD, NIMH, OD/ DPCPSI/ OAR
|
2005
|
|
Yale Specialized Center of Research (SCOR) on Gender-Sensitive Treatment for Tobacco Dependence
|
Research Initiative
|
FDA
|
NIDA
|
2011
|
|
|